Why the study?
The influence of clinical evidence on strategies implemented in the treatment of non-ST-segment elevation acute coronary syndromes was not known in Argentina.
How do clinical characteristics, management strategies, and in-hospital events of NSTEACS compare between 1999 and 2011 in Argentina?
Cross-Sectional (n=690)
Yes
How do clinical characteristics, management strategies, and in-hospital events of NSTEACS compare between 1999 and 2011 in Argentina?
Absolute Event Rate: 7.2% vs 5.9%
p-value: p=ns
Despite an increase in patient risk profile and more frequent use of invasive strategies over a 12-year period, in-hospital mortality and MI rates for NSTEACS in Argentina remained unchanged.
Background: The influence of clinical evidence on strategies implemented in the treatment of non-ST-segment elevation acute coronary syndromes (NSTEACS) is not known in our setting. Objectives: The aim of this study was to evaluate the differences in clinical characteristics, strategies adopted, therapeutic management and in-hospital events of NSTEACS in participating centers from two registries in Argentina. Methods: Patients included in participating centers of the STRATEG-SIA registry (1999) and SCAR registry (Síndromes Coronarios Agudos en Argentina - 2011) were compared. Results: We analyzed 238 patients of the STRATEG-SIA registry and 452 of the SCAR registry in 36 centers. Most patients were men and <65 years (SCAR 57%, STRATEG-SIA 54%; p=ns). The SCAR group presented higher prevalence of hypertension (75% vs. 60%; p=0.001), dyslipidemia (63% vs. 51%; p=0.003), chronic heart failure (10.5% vs. 4.6%; p=0.02) and history of myocardial revascularization (30% vs. 17%; p=0.001). In the SCAR registry, the proportion of moderate and high-risk patients (TIMI risk score 3-4: 48% vs. 37%; 5-7: 18% vs. 8%; p=0.0001) was higher and coronary angiography was more frequent (71% vs. 50%; p=0.0001), with a twofold increase in the proportion of percutaneous coronary interventions and 50% reduction in the number of myocardial revascularization surgeries. There were no significant differences in the rate of mortality and myocardial infarction during hospitalization (7.2% vs. 5.9%; p=ns). Conclusions: Patients of the SCAR (2011) registry represent a group at higher risk. The differences in the rates of in-hospital events were not statistically significant.
No takes yet. Share an insight, caveat, or question.
Dionisio et al. (2025) conducted a cross-sectional in Non-ST-segment elevation acute coronary syndromes (NSTEACS) (n=690). Management in 2011 (SCAR registry) vs. Management in 1999 (STRATEG-SIA registry) was evaluated on In-hospital mortality and myocardial infarction (p=ns).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: